VR Analytical

http://www.chromatographyonline.com/lcgc_w/Hall_Part3

Join global industry and regulatory experts as they discuss current extractables and leachables (E&L) hot topics on pharmaceuticals, biopharmaceuticals, and medical devices. Extractables and leachables are an important consideration when developing medical products and devices. This conference will give you an insight into a number of different topics within the ever-changing world of E&L.

Gain insight to some of the important E&L areas for medical devices and pharmaceutical products

Learn about some of the key challenges within the field of E&L

Understand the science behind the testing

Representatives from the supply chain to pharma, biopharma, and medical devices

Members of the medical and medicinal product world wanting to know more about the challenges with E&L

Those new to the field of E&L wanting to learn some key aspects of the requirements

ISO 10993-18: Establishing an AET for Chemical Characterization of Medical Devices

Ted Heise, PhD, RAC – MED Institute, Managing Partner &Toxicologist, D&B ChemTox, LLC

Managing Change in This Rapidly Changing World of Extractables and Leachables

Nick Morley, Principal Scientist, Hall Analytical

Strategies to Overcome Challenges in Extractable Screening Studies

Rachel Sanig, Senior Scientist, Waters Corporation

What is the Future of Leachables and Extractables Assessment?

Dan Norwood, Principal Consultant, Feinberg Norwood & Associates Pharma Consulting

Qualification of screening methods, how is this achieved?


European E&L Strategic Director
Hall Analytical


RAC – MED Institute, Managing Partner & Toxicologist
D&B ChemTox, LLC


Principal Consultant
Feinberg Norwood & Associates Pharma Consulting

Webcasts

October 4, 2021 at 3pm BST | 10am EST | 4pm CEST
Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.

The Ever-Changing World of Extractables and Leachables: Lessons learned and future challenges

https://www.chromatographyonline.com/lcgc_w/extractables

Extractables and leachables (E&L) testing is an important area in medical device and medicinal products. Join us for this session to hear global industry and regulatory experts discuss current hot topics in E&L testing for pharmaceuticals, biopharmaceuticals, and medical devices. In this Covid 19 world there are urgent testing requirements to help battle this pandemic. This webcast will give you an insight to this ever-changing world of E&L.

Gain insight to some of the important E&L areas relevant to medical devices and pharmaceuticals, for both small and large molecules

Discover the importance of a team to solve E&L challenges: those with regulatory knowledge, toxicologists and analytical chemists.

Dennis Jenke, Chief Executive Scientist, Triad Scientific Solutions, LLC

Douglas J Ball, MS, DABT, Managing Partner & Toxicologist, D&B ChemTox, LLC

William Beierschmitt, Managing Partner & Toxicologist, D&B ChemTox, LLC

James Hathcock, PhD, Sr Director, Regulatory and Validation Strategy, Pall Biotech

Aaron Hineman, Inorganic Product Line Leader-Americas, PerkinElmer, Inc.

Nick Morley, Principal Scientist, Hall Analytical

Ron Brown, Toxicologist, Risk Science Consortium

Andrew Feilden, European E&L Strategic Director, Hall Analytical

: Wednesday, February 24, 2021 at 10am EST | 3pm GMT | 4pm CET

***Live: Wednesday, February 24, 2021 at 10am EST | 3pm GMT | 4pm CET***  Join global industry and regulatory experts as they discuss current E&L hot topics related to pharmaceuticals, biopharmaceuticals and medical devices. ***On demand available after final airing until Feb. 24, 2022***

The Ever-Changing World of Extractables and Leachables, Part 2 A Free Virtual Conference 

http://www.biopharminternational.com/bp_w/leachables

Join global industry and regulatory experts as they discuss E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices. Extractables and leachables are important considerations in the production of medical devices and medicinal products. While COVID-19 is around, new ventilators and delivery devices for vaccines require urgent testing. This conference offers insight into this ever-changing world of E&L.

Gain insight to some of the most important areas of E&L relevant to medical devices and pharmaceuticals, for both small and large molecules

Discover the importance of a team in solving E&L challenges: those with regulatory knowledge, toxicologists and analytical chemists

Ron Brown, Toxicologist, Risk Science Consortium

Philip Clay, Director and Principal Toxicologist, Chorley Consulting

Mike Hodgson, Analytical Scientist, Baxter

Andy Teasdale, Analytical Chemist, AstraZeneca

 Wednesday, Sept. 9, 2020 at 9am EDT | 2pm BST | 3pm CEST

On demand available after final airing until Sept. 9, 2021.

Join global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices.

Live:
Wednesday, Sept. 9, 2020 at 9am EDT | 2pm BST | 3pm CEST

On demand available after final airing until Sept. 9, 2021

VR Analytical

Articles